Depo-medrol
NDC Package 21695-952-05

11-digit billing NDC: 21695095205 · Billing unit: ML · 5 ML per package
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Depo-medrol is contraindicated in patients with known hypersensitivity to the product and its constituents.Intramuscular corticosteroid preparations are contraindicated for idiopathic thrombocytopenic purpura.DEPO-MEDROL Sterile Aqueous Suspension is contraindicated for intrathecal administration. Marketed by Rebel Distributors Corp, this product is identified by NDC 21695-952 and is authorized under FDA application NDA011757.

Identification & Billing

NDC Package Code
21695-952-05
Package Description
5 mL in 1 VIAL, MULTI-DOSE
Product Code
21695-952
11-Digit Billing Format
21695095205
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
5 ML
RxNorm Crosswalk
  • RxCUI: 1358610 - methylPREDNISolone acetate 40 MG/ML Injectable Suspension
  • RxCUI: 1358610 - methylprednisolone acetate 40 MG/ML Injectable Suspension
  • RxCUI: 1358612 - DEPO-Medrol 40 MG/ML Injectable Suspension
  • RxCUI: 1358612 - methylprednisolone acetate 40 MG/ML Injectable Suspension [Depo-Medrol]
  • RxCUI: 1358612 - Depo-Medrol 40 MG/ML Injectable Suspension

Clinical Specifications

Proprietary Name
Depo-medrol
Dosage Form
-
Usage Information
DEPO-MEDROL is contraindicated in patients with known hypersensitivity to the product and its constituents.Intramuscular corticosteroid preparations are contraindicated for idiopathic thrombocytopenic purpura.DEPO-MEDROL Sterile Aqueous Suspension is contraindicated for intrathecal administration. Reports of severe medical events have been associated with this route of administration. DEPO-MEDROL is contraindicated for use in premature infants because the formulation contains benzyl alcohol. (See WARNINGS and PRECAUTIONS, Pediatric Use.) DEPO-MEDROL is contraindicated in systemic fungal infections, except when administered as an intra-articular injection for localized joint conditions (see WARNINGS, Infections, Fungal Infections).

Regulatory & Marketing

Labeler Name
Rebel Distributors Corp
FDA Application #
NDA011757
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
05-28-1959
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 21695-952-05 identifies a specific commercial package of 5 ml in 1 vial, multi-dose of Depo-medrol, labeled by Rebel Distributors Corp. This product is billed per "ML" milliliter and contains an estimated amount of 5 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rebel Distributors Corp on May 28, 1959. The current certification is valid through December 31, 2017.

How is this Rebel Distributors Corp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 21695095205. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 5 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
21695-952-05
11-Digit CMS (5-4-2)
21695-0952-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.